logo-loader
EnergyOil & Gas
viewCaspian Sunrise

Caspian Sunrise soars after delivering long awaited deep well success

The deep A5 well tested at a rate of 3,500 bopd before the programme was paused to bring in high pressure equipment

onshore drilling operation
The AIM-quoted share shot up around 60% in Monday morning’s deal, changing hands above 14p.

With news from the deep A5 well in Kazakhstan, Caspian Sunrise Plc (LON:CASP) on Monday delivered the result that investors "have been waiting for" that’s according to stockbroker WH Ireland.

Caspian Sunrise said in a statement that the A5 well had yielded a rate of 3,500 barrels of oil per day in testing. The well was tested for 4 hours before being shut-in pending further testing with high-pressure equipment.

READ: Kazakhstan-focused oilfield developer Caspian Sunrise may have discovered third shallow oil structure

The AIM-quoted share shot up around 60% at just over 14p in Monday morning deals.

WH Ireland analyst Brendan Long, in a note, highlighted that pressure dynamics information suggests ‘excellent fluid communication’ between the A5 well and a ‘highly productive reservoir’.

“This is the moment we were waiting for and the production result materially exceeds the success case guidance of 2,000 b/d previously provided by the company,” Long said.

READ: Kazakhstan-focused oiler Caspian Sunrise is sitting on "something special", says chairman

He added: “Since relaunching itself under the name Caspian Sunrise, pursuant to a merger with Baverstock to consolidate a 99% operated interest in the BNG licence, the company has been on a tremendous growth trajectory in terms of the creation of shareholder value.”

WH Ireland this morning repeated a ‘buy’ recommendation and upgraded its price target to 28.6p per share from 22.2p, implying almost further 100% upside to Monday’s newly elevated price of around 14p.

Quick facts: Caspian Sunrise

Price: 10.2 GBX

AIM:CASP
Market: AIM
Market Cap: £192.03 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Primary Health Properties delivering 'impressive dividend track record and...

Proactive Research analyst Ed Stacey says Primary Health Properties (LON:PHP) has an impressive track record of dividend growth, increasing the payment every year since listing in 1997. On top of that he says they've delivered steady capital gains on its portfolio that have translated into...

2 hours, 53 minutes ago

2 min read